Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,711,000 | 5,953,000 | 4,562,000 | 2,964,000 | 1,354,000 |
| Depreciation Amortization | 374,000 | 1,189,000 | 861,000 | 557,000 | 268,000 |
| Accounts receivable | -34,000 | -71,000 | -129,000 | -194,000 | 81,000 |
| Accounts payable and accrued liabilities | -266,000 | -1,187,000 | -975,000 | 89,000 | 42,000 |
| Other Working Capital | -237,000 | -1,299,000 | -872,000 | -173,000 | 45,000 |
| Other Operating Activity | 554,000 | 2,456,000 | 2,053,000 | 803,000 | 338,000 |
| Operating Cash Flow | $2,102,000 | $7,041,000 | $5,500,000 | $4,046,000 | $2,128,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -95,000 | -479,000 | -365,000 | -252,000 | -121,000 |
| Net Acquisitions | -63,000 | -2,757,000 | -2,649,000 | -2,587,000 | -28,000 |
| Purchase Of Investment | -970,000 | -5,315,000 | -4,520,000 | -4,020,000 | -1,342,000 |
| Sale Of Investment | 444,000 | 2,359,000 | 1,579,000 | 1,103,000 | 33,000 |
| Other Investing Activity | 0 | 118,000 | 0 | 0 | 0 |
| Investing Cash Flow | $-684,000 | $-6,074,000 | $-5,955,000 | $-5,756,000 | $-1,458,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 23,000 | -23,000 | -406,000 | 88,000 | -6,000 |
| Debt Issued | N/A | 11,627,000 | 7,771,000 | 7,771,000 | N/A |
| Debt Repayment | -6,000 | -6,010,000 | -2,006,000 | -2,005,000 | 0 |
| Common Stock Issued | 85,000 | 268,000 | 210,000 | 169,000 | 77,000 |
| Common Stock Repurchased | -895,000 | -6,033,000 | -4,223,000 | -4,217,000 | -409,000 |
| Dividend Paid | -1,027,000 | -3,717,000 | -2,784,000 | -1,851,000 | -924,000 |
| Other Financing Activity | 26,000 | -40,000 | 12,000 | -10,000 | 43,000 |
| Financing Cash Flow | $-1,794,000 | $-3,928,000 | $-1,426,000 | $-55,000 | $-1,219,000 |
| Exchange Rate Effect | 16,000 | -338,000 | -300,000 | -307,000 | -294,000 |
| Beginning Cash Position | 5,100,000 | 8,399,000 | 8,399,000 | 8,399,000 | 8,399,000 |
| End Cash Position | 4,740,000 | 5,100,000 | 6,218,000 | 6,327,000 | 7,556,000 |
| Net Cash Flow | $-360,000 | $-3,299,000 | $-2,181,000 | $-2,072,000 | $-843,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,102,000 | 7,041,000 | 5,500,000 | 4,046,000 | 2,128,000 |
| Capital Expenditure | -95,000 | -479,000 | -365,000 | -252,000 | -121,000 |
| Free Cash Flow | 2,007,000 | 6,562,000 | 5,135,000 | 3,794,000 | 2,007,000 |